Bactiguard Holding AB’s Annual and Sustainability Report 2025

About this update from Bactiguard Holding Ab

The Annual and Sustainability Report 2025 for Bactiguard Holding AB (publ) is now available at ir.bactiguard.com/During 2025, we built a stronger foundation by sharpening our focus as a licensing company, strengthening existing partnerships, and solidifying our therapeutic areas where our coating technology can address significant unmet needs in medical device-related infections. While positioning ourselves to deliver our 2030 targets, we also improved profitability, driven by a disciplined approach to costs, while creating a solid base for sustainable growth.“Our existing license partnerships remain the backbone of our business. Together with our partners, we strengthened collaboration through enhanced ways of working and the achievement of important milestones for Bactiguard-coated products.” Christine Lind comments in her CEO statement.Read more in Bactiguard Holding AB’s Annual and Sustainability Report 2025hereFor further information, please contact:Patrick Bach, CFO +46 761 295 911About BactiguardBactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas where infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access.Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard is headquartered in Stockholm and is listed on Nasdaq Stockholm and is included in the Small-Cap segment.Read more about Bactiguard:www.bactiguard.comFollow Bactiguard onLinkedInThis information is information that Bactiguard Holding is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-16 07:00 CEST.Image A...

View stock analysis, news, and events for Bactiguard Holding Ab